A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Ramteke, G. J.
- Effectiveness of Transcutaneous Electrical Nerve Stimulator (TENS) in Reducing Neuropathic Pain in Patients with Diabetic Neuropathy
Authors
1 Department of Physiotherapy, Ravi Nair Physiotherapy College, DMIMS (DU) Sawangi (M) Wardha, IN
Source
Indian Journal of Physiotherapy & Occupational Therapy-An International Journal, Vol 7, No 1 (2013), Pagination: 11-13Abstract
Objective: To evaluate the effectiveness of TENS in reducing neuropathic pain in patients with Diabetic Neuropathy.Design: Prospective Experimental Study.
Participants and Outcome Measure: 20 Patients with a diagnosis of Diabetic Neuropathy were included in the study and they were explained regarding the treatment & its duration. Outcome measures were recorded before & after the treatment session using numerical pain rating scale.
Result: After collecting data statistical analysis was done using Student's paired t test to determine the effect of TENS and it showed a significant difference in reduction in pain post treatment.
Conclusion: It can be concluded that High frequency TENS can be given to Diabetic Neuropathy patients for three weeks to achieve pain reduction.
Keywords
Diabetes, Neuropathic Pain, Transcutaneous Electrical Nerve Stimulator
References
- Watkins PJ. Natural history of diabetic neuropathies. QJ Med. 1990; 77:1209 –1218.
- Crawford JM. The pancreas. In: Kumar V, Cotran RS, Robbins SL, eds. Basic Pathology. 6th ed. Philadelphia, Pa: WB Saunders Co; 1997:557–578.
- Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care. 1993; 16: 1446– 1452.
- Horowitz SH. Diabetic neuropathy. Clin Orthop. 1993; 296:78–85.
- Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993; 43: 817–824.
- Tavaloki M, Mojaddidi M, Fadavi H, Malik RA, Pathophysiology and treatment of painful diabetic neuropathy. Curr Pain Headache Rep. 2008; 12: 192–197.
- Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev. 1999; 7: 245–252.
- Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population e”40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27: 1591–1597.
- Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004; 21: 976–982.
- Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006; 29: 1518–1522.
- Boulton AJM. Management of diabetic peripheral neuropathy. Clin Diabetes. 2005; 23: 9–15.
- Tamer A, Yildiz S, Yildiz N, et al. The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience. MedPrinc Pract. 2006; 15: 190–194.
- Valensi P, Giroux C, Seeboth-Ghalavini B, Attali JR. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. J Diabetes Complications. 1997; 11: 27–34.
- Booya F, Bandarian F, Larijani B, et al. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005; 5:24.
- Marks JB. The forgotten complication. Clin Diab. 2005; 23: 3–4.
- American Diabetes Association survey finds most people with diabetes don’t know about highly prevalent, serious complication. w w w. d i a b e t e s . o r g / f o r - m e d i a / 2005pressreleases/ diabeticneuropathy.jsp. Accessed Sept. 21, 2009.
- Borssen B, Bergenheim, Lithner F. The epidemiology of foot lesions in diabetic patients aged 15-50 years. Diabetic Med. 1990; 7: 438–444.
- Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputation. In Diabetes in America. 2nd ed. 1995. Washington, DC. Department of Health and Human Services.
- Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care. 2003; 26: 1790–1795.
- Reiber GE, Vilekyte L, Bokyo EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999; 22: 157–162.
- Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care.1990; 13: 513–521. 22. Somers DL, Somers MF. Treatment of neuropathic pain in a patient with diabetic neuropathy using transcutaneous electrical nerve stimulation applied to the skin of the lumbar region. Phys Ther. 1999; 79: 767–775. 23. Dinesh Kumar, MD, Inderjeet S. Julka, MD, Michael S. Alvaro, DPM & Howard J. Marshall, DPM. Diabetic Peripheral Neuropathy. Effectiveness of electrotherapy and amitriptyline for symptomatic relief Diabetes Care. Diabetes Care.1998; 21: 1322- 1325.
- Health Related Quality of Life in Chronic Non Specific Low Back Pain Individuals with Type II Diabetes
Authors
1 Department of Musculoskeletal Physiotherapy, Ravi Nair Physiotherapy College, Sawangi(M) Wardha (Mah), IN
2 Department of Physiotherapy, Ravi Nair Physiotherapy College, Sawangi(M) Wardha (Mah), IN
Source
Indian Journal of Physiotherapy & Occupational Therapy-An International Journal, Vol 6, No 2 (2012), Pagination: 138-141Abstract
Background
Quality of life (QOL) is increasingly recognized as a key outcome of evaluation research. The SF-36 is a well-validated health status instrument measuring eight different health concepts for measuring HRQOL. Now a day, a work is needed to reliably and accurately measure health-related quality of life among individuals with chronic non-specific LBP with type II Diabetes in the community setting to optimize the effects of increasingly complex and intensive treatments for it.
Objective
Our aim of this study was to compare health status measured by SF-36 in Chronic Low Back Pain individuals with type-2 diabetics and non diabetics.
Methodology
In the present Observational Study a HRQOL questionnaire (generic SF-36v2) was administered to fifty (30 males and 20 Females) out patients of either sex, aged above 40 years with Chronic non specific Low back pain (LBP) with or without type II diabetes and selectively assigned to 1 of 2 groups: a group consists of 25 Non-Diabetics and a matched group consists 25 controlled Type II Diabetics of atleast 4 years of duration.
Results
Results revealed Health Related Quality of Life was affected in all the participants but it was more affected in group 2 than group 1. Furthermore, on comparing the health status of group 1 with group 2 showed that mental health in group 2 was significantly affected than Physical health in group 1.
Conclusion
Diabetes significantly affects "Health Related Quality Of Life" in individuals with Non specific LBP. Mental Health is significantly affected than Physical Health in individuals with Non specific LBP and Type II Diabetes.
Keywords
Health Related Quality of Life (HQOL), Type-2 diabetes, Nonspecific Low Back Pain (LBP), SF-36 v2 (Short Form-36 Health Survey-version 2)References
- Carr AJ, Thompson PW, Kirwan JR. Quality of Life Measures. British Journal of Rheumatology. 1996; 35:275– 281. doi: 10.1093/rheumatology/35.10.921
- Kaplan, RM. Profile versus utility based measures of outcome for clinical trials. Quality of life assessment in clinical trials methods and practice. Oxford, New York, Tokyo: Oxford University Press; 1998. pp. 69–90.
- Anderson RT, Aaronson NK, Bullinger M, McBee WL. A Review of the Progress Towards Developing Health- Related Quality of Life Instruments for International Clinical Studies and Outcomes Research. PharmacoEconomics. 1996;10:336–345
- Ware, JE., Jr . The SF-36 Health Survey. In: Spilker B. , editor. Quality of Life and Pharmacoecoeconomics in Clinical Trials. Second. Philadelphia: Lippincott-Raven Publishers; 1996. pp. 337–345.
- Anderson RM, Fitzgerald JT, Wisdom K, et al. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997;20:299-305
- Ann Swank, Diabetes Health. Nearly four of every five people will suffer from back pain at some time in their life. 1 January 2005.
- H S J Picavet , N Hoeymans Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study Annals of the Rheumatic Diseases 2004;63:723-729
- Rachel Peterson Kim, Steven V. Edelman, and Dennis D. Kim Musculoskeletal Complications of Diabetes Mellitus. Volume 19, Number 3, 2001 • CLINICAL DIABETES.
- Joslin’s DM,3rd ed: 1359-1361
- Hwee-Lin Wee, Yin-Bun Cheung. The impact of diabetes mellitus and other chronic medical conditions on healthrelated Quality of Life: Is the whole greater than the sum of its parts. Health and Quality of Life Outcomes 2005, 3:2doi:10.1186/1477-7525-3-2
- Ware JE, Kosinski M. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1, second edition. Lincoln (RI): Quality Metric Incorporated 2001
- Alison J et al. Problems with the performance of the SF- 36 among people with type 2 diabetes in general practice. Volume 10, Number 8 / September, 2001
- Susan L. Norris. Health related quality of life measured by SF-36 for adults with diabetes: a meta-analysis Current Diabetes Reports, Volume 5, Number 2 / March, 2005
- de Visser CL, Bibo HJ, Groenier KH, de Visser W, Jong Meyboom-de B. The influence of cardiovascular disease on quality of life in type 2 diabetics. Qual Life Res 2002, 11:249-261.
- Lloyd A, Sawyer W, Hopkinson P: Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health 2001, 4:392-400
- Woodcock AJ, Julious SA, Kinmonth AL, Campbell MJ; Diabetes Care From Diagnosis Group. Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res 2001;10:661-70.
- Robert D. Goldney. Diabetes, Depression, and Quality of Life-A population study: Diabetes Care 27:1066-1070, 2004 18. Lustman P, Clouse R. Treatment of depression in diabetes: impact on mood and medical outcome. J Psychosom Res 53:917–924, 2002.
- Yogesh Gautam et al. A cross-sectional study of QOL of diabetic patients at tertiary care hospitals in Delhi. IJCM :34,4: 346-350,2009
- Rubin RR, Peyrot M.Quality of life and diabetes. Diabetes Metab Res Rev 1999;15:205-18
- Lau Chuen-Yen1, Qureshi AK2, Scott SG Association between glycaemic control and quality of life in diabetes mellitus. Journal of postgraduate medicine, vol.50, issue: 3, page: 189-194, 2004.
- Task Force to Revise the National Standards: National standards for diabetes self-management education programs. Diabetes Educator 21:189–193, 1995
- Bartlett E: Historical glimpses of patient education in the United States. Patient Educ Counsel 8:135–149, 1986